1. Home
  2. NSPR vs ZBAO Comparison

NSPR vs ZBAO Comparison

Compare NSPR & ZBAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • ZBAO
  • Stock Information
  • Founded
  • NSPR 2005
  • ZBAO 2015
  • Country
  • NSPR Israel
  • ZBAO China
  • Employees
  • NSPR N/A
  • ZBAO N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • ZBAO
  • Sector
  • NSPR Health Care
  • ZBAO
  • Exchange
  • NSPR Nasdaq
  • ZBAO NYSE
  • Market Cap
  • NSPR 63.0M
  • ZBAO 70.9M
  • IPO Year
  • NSPR N/A
  • ZBAO 2024
  • Fundamental
  • Price
  • NSPR $2.72
  • ZBAO $1.51
  • Analyst Decision
  • NSPR Strong Buy
  • ZBAO
  • Analyst Count
  • NSPR 2
  • ZBAO 0
  • Target Price
  • NSPR $4.75
  • ZBAO N/A
  • AVG Volume (30 Days)
  • NSPR 27.8K
  • ZBAO 41.6K
  • Earning Date
  • NSPR 03-05-2025
  • ZBAO 11-04-2024
  • Dividend Yield
  • NSPR N/A
  • ZBAO N/A
  • EPS Growth
  • NSPR N/A
  • ZBAO N/A
  • EPS
  • NSPR N/A
  • ZBAO 0.06
  • Revenue
  • NSPR $6,821,000.00
  • ZBAO $25,274,784.00
  • Revenue This Year
  • NSPR $13.36
  • ZBAO $65.08
  • Revenue Next Year
  • NSPR $49.64
  • ZBAO $34.27
  • P/E Ratio
  • NSPR N/A
  • ZBAO $25.15
  • Revenue Growth
  • NSPR 24.70
  • ZBAO 29.25
  • 52 Week Low
  • NSPR $1.81
  • ZBAO $1.39
  • 52 Week High
  • NSPR $3.42
  • ZBAO $5.70
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 47.01
  • ZBAO N/A
  • Support Level
  • NSPR $2.50
  • ZBAO N/A
  • Resistance Level
  • NSPR $2.83
  • ZBAO N/A
  • Average True Range (ATR)
  • NSPR 0.20
  • ZBAO 0.00
  • MACD
  • NSPR -0.01
  • ZBAO 0.00
  • Stochastic Oscillator
  • NSPR 41.54
  • ZBAO 0.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About ZBAO ZHIBAO TECHNOLOGY INC

Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.

Share on Social Networks: